Home › Atrial Fibrillation › Oregon
Atrial Fibrillation clinical trials in Oregon
4 studies for Atrial Fibrillation are looking for participants at sites in Oregon.
Cities in Oregon
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 4
Ages 22 and older · All sexes · Updated Sep 23, 2026 · NCT06953726Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1075, Portland
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
- OHSU Knight Cancer Institute, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06067438Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Oregon Health & Science University Hospital, Portland
- Providence St. Vincent Medical Center, Portland
- PeaceHealth Sacred Heart Medical Center - RiverBend, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.